Glucose transport disorder

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:79178
Who is this for?
Show terms as
37Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Glucose transport disorder, also known as Glucose Transporter Type 1 Deficiency Syndrome (GLUT1 Deficiency Syndrome or GLUT1-DS), is a rare inherited condition where the brain cannot get enough glucose (sugar) to function properly. Glucose is the brain's main fuel source, and a special protein called GLUT1 acts like a doorway to carry glucose from the blood into the brain. When this protein does not work correctly, the brain is starved of energy, especially during times of fasting or illness. The condition affects people in different ways, but the most common symptoms include seizures that are hard to control, delays in development, problems with movement and coordination, and difficulties with thinking and learning. Symptoms often begin in infancy or early childhood. Some people have a milder form with movement problems but fewer or no seizures. The main treatment is a special high-fat, low-carbohydrate diet called the ketogenic diet. This diet teaches the body to use fat-based molecules called ketones as an alternative fuel for the brain, which can dramatically reduce seizures and improve development in many patients. Early diagnosis and starting the diet as soon as possible are very important for the best outcomes. There is currently no cure, but dietary therapy can significantly improve quality of life.

Key symptoms:

Seizures that are difficult to control with standard medicationsDevelopmental delays (slower to reach milestones like talking or walking)Intellectual disability or learning difficultiesProblems with coordination and balance (ataxia)Involuntary eye movements (opsoclonus or nystagmus)Muscle stiffness or abnormal muscle toneEpisodes of confusion or altered alertnessHeadachesFatigue and low energy, especially before meals or when fastingSpeech and language difficultiesMovement problems that come and go (paroxysmal dyskinesia)Slowed head growth (acquired microcephaly in some cases)

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Infantile

Begins in infancy, roughly 1 month to 2 years old

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Jul 2026Evaluation of the Safety and Effectiveness of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in Adults Living With Type 1 Diabetes

Medtronic Diabetes — NA

TrialNOT YET RECRUITING
Jun 2026Evaluation of the Safety and Performance of the Novel Medtronic Experimental Automated Insulin Delivery System (NMX8) in People Living With Diabetes (NEXUS)

Medtronic Diabetes — NA

TrialNOT YET RECRUITING
Apr 2026The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment

Helsinki University Central Hospital — NA

TrialNOT YET RECRUITING
Apr 2026Remotely Delivered Mindfulness-Based Diabetes Education

University of Alabama at Birmingham — NA

TrialNOT YET RECRUITING
Mar 2026The Postprandial Hypo-Avoid Study

Steno Diabetes Center Copenhagen — PHASE4

TrialNOT YET RECRUITING
Mar 2026The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France

Tandem Diabetes Care, Inc.

TrialRECRUITING
Mar 2026Early Automated Insulin Delivery (AID) Pilot for Newly Diagnosed T1D

Stanford University — NA

TrialNOT YET RECRUITING
Mar 2026Food Sequencing in Food Insecurity

Weill Medical College of Cornell University — NA

TrialNOT YET RECRUITING
Mar 2026Hybrid Closed-Loop Insulin Delivery After Pancreatectomy

Centre Hospitalier Sud Francilien — NA

TrialNOT YET RECRUITING
Mar 2026Comparing Effectiveness of Primary Care-Delivered Telehealth Interventions to Manage Type 2 Diabetes in People With Physical Disabilities and Multiple Chronic Conditions

University of Alabama at Birmingham — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Glucose transport disorder.

View clinical trials →

No actively recruiting trials found for Glucose transport disorder at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Glucose transport disorder community →

Specialists

Showing 25 of 37View all specialists →
MP
Mauro P Santamaria, PhD
HAZARD, KY
Specialist
PI on 3 active trials
NM
Nelly Mauras, MD
JACKSONVILLE, FL
Specialist
PI on 6 active trials
BM
Benjamin M Scirica, MD MPH
BOSTON, MA
Specialist
PI on 1 active trial
SM
Sabine Hofer, MD
Specialist
PI on 1 active trial
KM
Kaberi Dasgupta, MD, MSc
Specialist
PI on 2 active trials
DO
David Norman O'neal
Specialist
PI on 1 active trial
MM
Michael Roden, Prof., MD
PICKERINGTON, OH
Specialist
PI on 5 active trials
AP
Amber W Kinsey, PhD
EAST CLEVELAND, OH
Specialist
PI on 1 active trial
JM
Jordan Pinsker, MD
SANTA BARBARA, CA
Specialist
PI on 7 active trials
MM
Margaret Zupa, MDMS
PITTSBURGH, PA
Specialist
PI on 1 active trial
EP
Eyal Dassau, PhD
Specialist
PI on 4 active trials
CP
Carine de Beaufort, PhD
Specialist
PI on 1 active trial
JP
Jill Kanaley, PhD
Specialist
PI on 2 active trials
MC
Monica M. DiNardo, PhD ARNP CDE
PITTSBURGH, PA
Specialist
PI on 1 active trial
LP
Lora Giangregorio, PhD
Specialist
PI on 1 active trial
FM
Fiona Campbell, MD
LAUDERDALE LAKES, FL
Specialist
PI on 1 active trial
SM
Sue Brown, MD
Specialist
PI on 5 active trials
CM
Carlo Acerini, MD
Specialist
PI on 1 active trial
BM
Birgit Rami-Merhar, MD
Specialist
PI on 1 active trial
AM
Archana Singh, MDS
Specialist
PI on 1 active trial
EM
Elke Fröhlich-Reiterer, MD
Specialist
PI on 1 active trial
TM
Thomas Kapellen, MD
Specialist
PI on 1 active trial
LC
Linda Siminerio, RN, PhD, CDE
Specialist
PI on 2 active trials
JM
John Lum, MS
WATERBURY, CT
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Glucose transport disorder.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Glucose transport disorderForum →

No community posts yet. Be the first to share your experience with Glucose transport disorder.

Start the conversation →

Latest news about Glucose transport disorder

Disease timeline:

New recruiting trial: Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: Intramyocellular Fatty Acid Trafficking in Insulin Resistance States - Effects of Intestinal Delivery of Lipids

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: Primary Care Pragmatic, Real World Experience for Automated Insulin Delivery

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: Examining Digital Health Care Delivery Models Through Medicaid Collaborative

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: Occupational Therapy and Registered Dietitian Services to Reduce Fall Risk Among Home Delivered Meal Clients

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: Brain Blood Flow and Sugar Transport in Alzheimer's Disease With and Without Diabetes - A Pilot Imaging Study

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: Vey Low-Energy Ketogenic Therapy in Adults With Type 1 Diabetes and Obesity on Intensive Insulin Therapy Using Advanded Hybrid Closed Loop System

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: Hybrid Closed-Loop for Perioperative Glycemic Control in T2DM With Parenteral Nutrition

A new clinical trial is recruiting patients for Glucose transport disorder

New recruiting trial: Brain Blood Flow and Lactate in Non-obese and Obese Subjects

A new clinical trial is recruiting patients for Glucose transport disorder

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is the ketogenic diet the right treatment for my child right now, and how soon should we start?,Which anti-seizure medications should we avoid because they might make things worse?,How often should we check CSF glucose and blood glucose levels?,What nutritional supplements does my child need while on the ketogenic diet?,What should I do if my child gets sick and cannot eat — how do I manage fasting safely?,Are there any clinical trials or new treatments we should consider?,What educational and developmental support services should we be accessing?

Common questions about Glucose transport disorder

What is Glucose transport disorder?

Glucose transport disorder, also known as Glucose Transporter Type 1 Deficiency Syndrome (GLUT1 Deficiency Syndrome or GLUT1-DS), is a rare inherited condition where the brain cannot get enough glucose (sugar) to function properly. Glucose is the brain's main fuel source, and a special protein called GLUT1 acts like a doorway to carry glucose from the blood into the brain. When this protein does not work correctly, the brain is starved of energy, especially during times of fasting or illness. The condition affects people in different ways, but the most common symptoms include seizures that ar

How is Glucose transport disorder inherited?

Glucose transport disorder follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Glucose transport disorder typically begin?

Typical onset of Glucose transport disorder is infantile. Age of onset can vary across affected individuals.

Which specialists treat Glucose transport disorder?

25 specialists and care centers treating Glucose transport disorder are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.